Lobular and non-lobular breast cancers differ regarding axillary lymph node metastasis: A cross-sectional study on 4,292 consecutive patients

Breast Cancer Research and Treatment

Volumn 128, Issue 2, 2011, Pages 429-435

  Vandorpe, T ^a,b   Smeets, A ^a   Van Calster, B ^b   Van Hoorde, K ^b   Leunen, K ^a   Amant, F ^a   Moerman, Ph ^a   Deraedt, K ^a   Brouckaert, O ^a   Van Huffel, S ^b   Wildiers, H ^a   Christiaens, M R ^a   Neven, P ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Breast cancer; Invasive lobular carcinoma; Lymph node

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; STEROID RECEPTOR;

AGE; ARTICLE; AXILLARY LYMPH NODE; BELGIUM; BREAST CARCINOMA; BREAST SURGERY; CANCER CLASSIFICATION; CANCER INCIDENCE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENTINEL LYMPH NODE; TUMOR VOLUME;

AGED; AXILLA; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 79959729492     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-011-1565-4     Document Type: Article

References (28)

1. NR Patani MV Dwek M Douek 2007 Predictors of axillary lymph node metastasis in breast cancer: a systematic review Eur J Surg Oncol 33 4 409 419 17125963 1:STN:280:DC%2BD2s3jvVWksQ%3D%3D (Pubitemid 46591166)
2. G Arpino VJ Bardou GM Clark RM Elledge 2004 Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome Breast Cancer Res 6 3 R149 R156 15084238 10.1186/bcr767
3. M Cristofanilli A Gonzalez-Angulo N Sneige SW Kau K Broglio RL Theriault V Valero AU Buzdar H Kuerer TA Buccholz, et al. 2005 Invasive lobular carcinoma classic type: response to primary chemotherapy and survival outcomes J Clin Oncol 23 1 41 48 15625359 10.1200/JCO.2005.03.111 (Pubitemid 41702621)
4. BC Pestalozzi D Zahrieh E Mallon BA Gusterson KN Price RD Gelber SB Holmberg J Lindtner R Snyder B Thurlimann, et al. 2008 Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast: combined results of 15 International Breast Cancer Study Group clinical trials J Clin Oncol 26 18 3006 3014 18458044 10.1200/JCO.2007.14.9336
5. M Tubiana-Hulin D Stevens S Lasry JM Guinebretiere L Bouita C Cohen-Solal P Cherel J Rouesse 2006 Response to neoadjuvant chemotherapy in lobular and ductal breast carcinomas: a retrospective study on 860 patients from one institution Ann Oncol 17 8 1228 1233 16740599 10.1093/annonc/mdl114 1:STN:280:DC%2BD28vkvVOrsA%3D%3D (Pubitemid 44288213)
6. G Viale S Zurrida E Maiorano G Mazzarol G Pruneri G Paganelli P Maisonneuve U Veronesi 2005 Predicting the status of axillary sentinel lymph nodes in 4351 patients with invasive breast carcinoma treated in a single institution Cancer 103 3 492 500 15612028 10.1002/cncr.20809
7. N Wasif MA Maggard CY Ko AE Giuliano 2010 Invasive lobular vs. ductal breast cancer: a stage-matched comparison of outcomes Ann Surg Oncol 17 7 1862 1869 20162457 10.1245/s10434-010-0953-z
8. P Neven B Van Calster I Van den Bempt S Van Huffel V Van Belle W Hendrickx J Decock H Wildiers R Paridaens F Amant, et al. 2008 Age interacts with the expression of steroid and HER-2 receptors in operable invasive breast cancer Breast Cancer Res Treat 110 1 153 159 17687649 10.1007/s10549-007-9687-4 1:CAS:528:DC%2BD1cXmslOqu7g%3D (Pubitemid 351793852)
9. Hastie T, Tibshirani R (1990) Generalized additive models, 1st edn. Chapman and Hall, London; New York
10. M Tubiana 1998 Benefits and limitations of mass screening. The natural history of breast cancer Bull Acad Natl Med 182 8 1593 1610 10188306 1:STN:280:DyaK1M3gsVWhsw%3D%3D discussion 1610-1591
11. JL Bevilacqua MW Kattan JV Fey HS Cody III PI Borgen KJ Van Zee 2007 Doctor, what are my chances of having a positive sentinel node? A validated nomogram for risk estimation J Clin Oncol 25 24 3670 3679 17664461 10.1200/JCO.2006.08.8013 (Pubitemid 47372606)
12. AC Voogd OJ Repelaer van Driel RM Roumen MA Crommelin MW van Beek JW Coebergh 1997 Changing attitudes towards breast-conserving treatment of early breast cancer in the south-eastern Netherlands: results of a survey among surgeons and a registry-based analysis of patterns of care Eur J Surg Oncol 23 2 134 138 9158187 10.1016/S0748-7983(97)80006-6 1:STN:280:DyaK2szgtFyjuw%3D%3D (Pubitemid 27223006)
13. PH Gann SA Colilla SM Gapstur DJ Winchester DP Winchester 1999 Factors associated with axillary lymph node metastasis from breast carcinoma: descriptive and predictive analyses Cancer 86 8 1511 1519 10526280 10.1002/(SICI)1097-0142(19991015)86:8<1511::AID-CNCR18>3.0.CO;2-D 1:STN:280:DC%2BD3c%2FhtVSjsw%3D%3D (Pubitemid 29489785)
14. IA Olivotto JS Jackson D Mates S Andersen W Davidson CJ Bryce J Ragaz 1998 Prediction of axillary lymph node involvement of women with invasive breast carcinoma: a multivariate analysis Cancer 83 5 948 955 9731899 10.1002/(SICI)1097-0142(19980901)83:5<948::AID-CNCR21>3.0.CO;2-U 1:STN:280:DyaK1cvgtVKhtw%3D%3D (Pubitemid 28401929)
15. V Velanovich W Szymanski 1998 Lymph node metastasis in breast cancer: common prognostic markers lack predictive value Ann Surg Oncol 5 7 613 619 9831110 10.1007/BF02303831 1:STN:280:DyaK1M%2Fks12ksQ%3D%3D (Pubitemid 28523250)
16. AC Voogd JW Coebergh OJ Repelaer van Driel RM Roumen MW van Beek A Vreugdenhil MA Crommelin 2000 The risk of nodal metastases in breast cancer patients with clinically negative lymph nodes: a population-based analysis Breast Cancer Res Treat 62 1 63 69 10989986 10.1023/A:1006447825160 1:STN:280:DC%2BD3cvkt1Snsw%3D%3D (Pubitemid 30609564)
17. X Sastre-Garau M Jouve B Asselain A Vincent-Salomon P Beuzeboc T Dorval JC Durand A Fourquet P Pouillart 1996 Infiltrating lobular carcinoma of the breast. Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns Cancer 77 1 113 120 8630916 10.1002/(SICI)1097-0142(19960101)77:1<113::AID-CNCR19>3.0.CO;2-8 1:STN:280:DyaK283itlensg%3D%3D (Pubitemid 26002745)
18. G Cserni 2006 Histopathologic examination of the sentinel lymph nodes Breast J 12 5 Suppl 2 S152 S156 16958995 10.1111/j.1075-122X.2006.00336.x (Pubitemid 44337462)
19. DT Patil B Susnik 2008 Keratin immunohistochemistry does not contribute to correct lymph node staging in patients with invasive lobular carcinoma Hum Pathol 39 7 1011 1017 18400255 10.1016/j.humpath.2007.11.017 1:CAS:528:DC%2BD1cXnsF2qurg%3D
20. E Maiorano MM Regan G Viale MG Mastropasqua M Colleoni M Castiglione-Gertsch KN Price RD Gelber A Goldhirsch AS Coates 2010 Prognostic and predictive impact of central necrosis and fibrosis in early breast cancer: results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy Breast Cancer Res Treat 121 1 211 218 19280340 10.1007/s10549-009-0360-y
21. S Zurrida A Morabito V Galimberti A Luini M Greco C Bartoli R Raselli N Rossi G Vessecchia N Cascinelli, et al. 1999 Importance of the level of axillary involvement in relation to traditional variables in the prognosis of breast cancer Int J Oncol 15 3 475 480 10427127 1:STN:280:DyaK1Mzlsl2jtg%3D%3D
22. L Da Silva S Parry L Reid P Keith N Waddell M Kossai C Clarke SR Lakhani PT Simpson 2008 Aberrant expression of E-cadherin in lobular carcinomas of the breast Am J Surg Pathol 32 5 773 783 18379416 10.1097/PAS.0b013e318158d6c5 (Pubitemid 351600817)
23. EA Rakha D Abd El Rehim SE Pinder SA Lewis IO Ellis 2005 E-cadherin expression in invasive non-lobular carcinoma of the breast and its prognostic significance Histopathology 46 6 685 693 15910600 10.1111/j.1365-2559.2005. 02156.x 1:STN:280:DC%2BD2M3mvV2isw%3D%3D (Pubitemid 40834828)
24. JS Michaelson M Silverstein J Wyatt G Weber R Moore E Halpern DB Kopans K Hughes 2002 Predicting the survival of patients with breast carcinoma using tumor size Cancer 95 4 713 723 12209713 10.1002/cncr.10742 (Pubitemid 34839661)
25. HM Verkooijen G Fioretta G Vlastos A Morabia H Schubert AP Sappino MF Pelte P Schafer J Kurtz C Bouchardy 2003 Important increase of invasive lobular breast cancer incidence in Geneva, Switzerland Int J Cancer 104 6 778 781 12640687 10.1002/ijc.11032 1:CAS:528:DC%2BD3sXjtVWqtrY%3D (Pubitemid 36418517)
26. AR Dixon IO Ellis CW Elston RW Blamey 1991 A comparison of the clinical metastatic patterns of invasive lobular and ductal carcinomas of the breast Br J Cancer 63 4 634 635 1850613 10.1038/bjc.1991.145 1:STN:280:DyaK3M3hsVygsA%3D%3D
27. E Gudlaugsson I Skaland EA Janssen PJ van Diest FJ Voorhorst K Kjellevold A zur Hausen JP Baak 2010 Prospective multicenter comparison of proliferation and other prognostic factors in lymph node negative lobular invasive breast cancer Breast Cancer Res Treat 121 1 35 40 19568929 10.1007/s10549-009-0442-x 1:CAS:528:DC%2BC3cXkvVymtLY%3D
28. S Toikkanen L Pylkkanen H Joensuu 1997 Invasive lobular carcinoma of the breast has better short- and long-term survival than invasive ductal carcinoma Br J Cancer 6 9 1234 1240 10.1038/bjc.1997.540 (Pubitemid 27448024)